avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Jun
|
ENSMUSG00000052684.3 | jun proto-oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Jun | mm10_v2_chr4_-_95052188_95052222 | 0.09 | 5.9e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 14.8 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
2.1 | 6.4 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.1 | 6.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.9 | 9.6 | GO:1904970 | brush border assembly(GO:1904970) |
1.8 | 12.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.7 | 5.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.6 | 6.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.4 | 9.7 | GO:0006108 | malate metabolic process(GO:0006108) regulation of NADP metabolic process(GO:1902031) |
1.2 | 3.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.1 | 3.3 | GO:0060748 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.1 | 7.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 3.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.0 | 4.0 | GO:0090472 | dibasic protein processing(GO:0090472) |
1.0 | 4.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.8 | 2.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 2.0 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.7 | 3.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 2.6 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.6 | 4.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.6 | 6.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.6 | 3.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 2.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.6 | 5.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.7 | GO:0015881 | creatine transport(GO:0015881) |
0.6 | 2.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.5 | 4.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 6.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 4.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 14.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 3.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.4 | 2.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 2.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.4 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 3.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 1.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.3 | 3.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.3 | 2.2 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 2.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.5 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.2 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.3 | 2.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 2.6 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.3 | 7.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 2.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 5.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.1 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 2.1 | GO:0098881 | synaptic vesicle docking(GO:0016081) exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.3 | 1.8 | GO:1901098 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 3.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 2.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.2 | 6.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 4.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.3 | GO:0002461 | complement receptor mediated signaling pathway(GO:0002430) tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 2.2 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 2.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 3.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 3.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 2.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 2.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.0 | GO:0048861 | histone H3-K27 acetylation(GO:0043974) leukemia inhibitory factor signaling pathway(GO:0048861) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.6 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 1.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 5.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 3.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 2.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 1.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 4.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 6.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 2.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:0072276 | cell migration involved in vasculogenesis(GO:0035441) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.1 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 3.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 1.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 2.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 4.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 1.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 1.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 2.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 23.0 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.1 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 5.9 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 2.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 2.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 5.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 5.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 4.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 1.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 1.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 1.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 3.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 3.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 3.1 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 1.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.3 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 1.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 1.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 1.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.6 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.0 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.1 | 14.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 9.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.9 | 4.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.9 | 6.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 2.4 | GO:0044753 | amphisome(GO:0044753) |
0.6 | 3.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 8.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 3.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 5.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 4.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.0 | GO:0031673 | H zone(GO:0031673) |
0.3 | 3.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 3.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 1.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 3.3 | GO:0031105 | septin complex(GO:0031105) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.8 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 6.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 11.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 4.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 10.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 8.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 6.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 4.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 1.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 4.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 6.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 6.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 3.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 12.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 3.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 3.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 3.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 1.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
3.2 | 12.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
2.1 | 6.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 6.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 7.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 3.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.1 | 3.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.1 | 7.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.1 | 3.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.9 | 3.6 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.9 | 5.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.8 | 2.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 2.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 3.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 6.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 2.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.6 | 14.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 3.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 1.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 1.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 3.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 2.0 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 10.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.4 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 5.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 4.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 3.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 2.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 4.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.9 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.3 | 1.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 6.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 4.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 38.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 4.7 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 3.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 7.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 1.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 2.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 5.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 3.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
0.2 | 3.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 4.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 4.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.5 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 2.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 5.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 11.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.1 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 3.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 2.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 4.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 4.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 6.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 5.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 2.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 2.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 3.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 8.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 2.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 2.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 9.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 2.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 6.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 1.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 5.4 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 1.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 2.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 2.9 | GO:0048037 | cofactor binding(GO:0048037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 14.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 4.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 19.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 11.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 7.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 13.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 4.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 4.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 6.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 7.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 8.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.5 | 5.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 15.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 4.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 3.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 2.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 9.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 9.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 3.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 4.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 2.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |